Pharmaceutical News

RSS

PROCOVAXED: Promoting COVID vaccination in emergency departments

Researchers examine the reasons behind COVID-19 vaccine hesitancy emergency department patients when educated through vaccine messaging platforms.

22 Mar 2022

Rubella antibodies vs. COVID-19

A new study describes a potential relationship between antibody titers against the rubella virus and the severity of COVID-19.

22 Mar 2022

A circRNA COVID vaccine with potential to neutralize SARS-CoV-2 variants

Researchers demonstrate the broad neutralization potential of a strategically engineered circRNA using mice as a model system.

21 Mar 2022

Study links the usage of oral polio vaccines with lower incidence of COVID-19

A study published in the journal PLOS ONE showed how countries using oral polio vaccine have a lower incidence of coronavirus disease (COVID-19) when compared to those using inactivated polio vaccine – suggesting that the oral vaccine may either prevent the infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the individual level or slow down the transmission in the community.

21 Mar 2022

Response to COVID-19 boosters in seronegative multiple sclerosis patients

Researchers report humoral T-cell responses in seronegative MS patients after receiving a third COVID-19 booster vaccine dose.

20 Mar 2022

Sinovac COVID vaccine shows modest efficacy against SARS-CoV-2 infection in children 3 to 5 years

Researchers investigate the efficacy of CoronaVac, COVID-19 vaccine developed by Sinovac Biotech, in children aged three to five years.

20 Mar 2022

Researchers find ketamine to have significant anti-depressant and anti-suicidal effects

First manufactured more than 50 years ago, ketamine is a fast-acting dissociative anesthetic often used in veterinary and emergency medicine. Ketamine also has a history of being an illicit party drug.

18 Mar 2022

Impact of new COVID vaccinations as novel variants emerge

Researchers explores the changing value of COVID-19 vaccines in a scenario of dynamic immunity and rapidly evolving variants of concern.

17 Mar 2022

Single dose of Pfizer vaccine reduces risk of SARS-CoV-2 infection in kids

Researchers discuss the efficacy of COVID-19 vaccines in young people and children when the SARS-CoV-2 Delta- and Omicron-dominant periods.

17 Mar 2022

BNT162b2 booster vaccination induces robust humoral and cellular immune responses

Scientists evaluate the humoral and cellular immune responses in individuals who have received a third booster dose of mRNA-based COVID-19 vaccine.

17 Mar 2022

It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

As immunocompromised people across the country work to get Evusheld, a potentially lifesaving covid therapy, several hundred providers of the injections were removed from a federal dataset on Wednesday night, making the therapy even harder to locate.

17 Mar 2022

MHRA authorizes new medicine for COVID-19 prevention

A new medicine, Evusheld (tixagevimab/cilgavimab), has today been authorised for COVID-19 prevention by the Medicines and Healthcare products Regulatory Agency (MHRA) after meeting the UK regulatory standards of safety, quality and effectiveness.

17 Mar 2022

Young adults protected by booster COVID-19 vaccine during Omicron dominant period

Researchers estimate the impact of COVID-19 booster doses on infection in a vaccinated population of young adults during Omicron-dominant period.

16 Mar 2022

The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

We speak to Dr. Alemnew Dagnew from the Bill & Melinda Gates Medical Research Institute, about their tuberculosis vaccine study and the future of tuberculosis.

16 Mar 2022

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

In a recent research paper currently available on bioRxiv* preprint server, scientists from the University of Oxford in the United Kingdom and the University of Auckland in New Zealand identified several structural specificities of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may serve as viable starting points for the development and optimization of viral inhibitors against coronavirus disease 2019 (COVID-19) and other future threats.

16 Mar 2022

Ethyl lauroyl arginine hydrochloride (ELAH) nasal spray as potent antiviral against SARS-CoV-2

Researchers evaluate the virucidal effects of ELAH against SARS-CoV-2 and human coronavirus-229E in a nasal spray formulation.

15 Mar 2022

Acacetin shows potency against SARS-CoV-2 spike protein

Researchers use molecular docking to screen phytocompounds and evaluate their binding affinity with SARS-CoV-2.

15 Mar 2022

Anti-spike IgG dynamics after 2nd BNT162b2 COVID-19 vaccine dose in Japanese health care workers

Researchers investigate the dynamics of anti-spike IgG levels against the SARS-CoV-2 spike protein in Japanese healthcare workers.

15 Mar 2022

Zentalis contributes $1 million to SU2C Catalyst program for research into targeted cancer therapeutics

Stand Up To Cancer and Zentalis Pharmaceuticals, Inc. today announced that Zentalis will contribute $1 million to the SU2C Catalyst program to support research that investigates the use of certain small molecule inhibitors for treating a variety of cancer types.

15 Mar 2022

High doses of antibiotic may safely and effectively treat TB meningitis

A Johns Hopkins Children's Center-led study in animals suggests that high doses of a widely used antibiotic called rifampin may safely treat and reduce the duration of treatment for the deadliest form of tuberculosis that affects the brain, potentially improving survival rates for patients and decreasing the likelihood of lasting adverse effects of the disease.

15 Mar 2022

Previous
1
...
84
85
86
87
88
89
90
...
1434
Next

Pharmaceutical News

PROCOVAXED: Promoting COVID vaccination in emergency departments

Rubella antibodies vs. COVID-19

A circRNA COVID vaccine with potential to neutralize SARS-CoV-2 variants

Study links the usage of oral polio vaccines with lower incidence of COVID-19

Response to COVID-19 boosters in seronegative multiple sclerosis patients

Sinovac COVID vaccine shows modest efficacy against SARS-CoV-2 infection in children 3 to 5 years

Researchers find ketamine to have significant anti-depressant and anti-suicidal effects

Impact of new COVID vaccinations as novel variants emerge

Single dose of Pfizer vaccine reduces risk of SARS-CoV-2 infection in kids

BNT162b2 booster vaccination induces robust humoral and cellular immune responses

It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

MHRA authorizes new medicine for COVID-19 prevention

Young adults protected by booster COVID-19 vaccine during Omicron dominant period

The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

Ethyl lauroyl arginine hydrochloride (ELAH) nasal spray as potent antiviral against SARS-CoV-2

Acacetin shows potency against SARS-CoV-2 spike protein

Anti-spike IgG dynamics after 2nd BNT162b2 COVID-19 vaccine dose in Japanese health care workers

Zentalis contributes $1 million to SU2C Catalyst program for research into targeted cancer therapeutics

High doses of antibiotic may safely and effectively treat TB meningitis

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News